Endocrinology

DKA Knowledge Challenge!

Diabetic ketoacidosis isn’t just an emergency room concern. It can start with subtle signs you might see first in your patients. This quick quiz zeroes in on the key red flags, risk factors, and management essentials of DKA that every PCP should know. Test your knowledge and sharpen your clinical instincts - it could make all the difference.

Click here to participate in survey

Latest News

Novo Nordisk Advances Amycretin SC and Oral into Phase 3 Development for Weight Management /image credit ©Remigiusz Góra/stock.adobe.com

Novo's GLP-1/Amylin Dual Agonist Amycretin to Enter Late-Stage Trials for Obesity

By Grace Halsey

June 13th 2025

Both oral and subcutaneous formulations of the long-acting GLP-1 and amylin receptor agonist move into stage 3 clinical trials following positive feedback from regulators.